Overview
To develop a database of medical information about patients with MLA in an effort to increase our understanding of the characteristics of MLA, which is the rarest form of endometrial carcinoma.
Description
Primary Objectives
- To collect, both prospectively and retrospectively, data on participants characteristics, disease characterization, pathology and molecular data, treatment, and outcomes for participants with gynecologic mesonephric-like adenocarcinoma (MLA).
Secondary Objectives
- To organize clinical information to support multifaceted queries of participant characteristics, treatment, and disease outcome data and to facilitate correlation of these characteristics with participant outcome.
- To have a single data repository kept on a secure platform that will integrate clinical information and research findings and serve as an archive for future research.
Eligibility
Inclusion Criteria:
- Adult patients with a diagnosis of gynecologic mesonephric-like adenocarcinoma (MLA).
- Patients can also be diagnosed with mesonephric adenocarcinoma (MA) or patients with mesonephric and mesonephric-like carcinosarcomas.
- Patients who are receiving or have received treatment at any facility, including but not limited to MD Anderson Cancer Center are eligible.
- Patients may be residents of any country and be of any ethnic background.
- Patients who request to participate in the registry, regardless of the method by which they learned of it, are eligible to participate.
- Patients who do not speak English can be eligible if accompanied by an institutional interpreter.
Exclusion Criteria:
- Patients with other subtypes of EACs.